Suppr超能文献

从慢性乙型肝炎的过度到不足综合征:miRNA 阵列数据的动态网络分析。

Progression from Excessive to Deficient Syndromes in Chronic Hepatitis B: A Dynamical Network Analysis of miRNA Array Data.

机构信息

Research Center for TCM Complexity System, Shanghai University of TCM, Shanghai 201203, China.

出版信息

Evid Based Complement Alternat Med. 2013;2013:945245. doi: 10.1155/2013/945245. Epub 2013 Apr 16.

Abstract

Traditional Chinese medicine (TCM) treatment is regarded as a safe and effective method for chronic hepatitis B (CHB), which requires a traditional diagnosis method to distinguish the TCM syndrome. In this study, we study the differences and similarities among excessive, excessive-deficient, and deficient syndromes, by an integrative and comparative analysis of weighted miRNA expression or miRNA-target network in CHB patients. We first calculated the differential expressed miRNAs based on random module t-test and classified three CHB TCM syndromes using SVM method. Then, miRNA target genes were obtained by validated database and predicted programs subsequently, the weighted miRNA-target networks were constructed for different TCM syndromes. Furthermore, prioritize target genes of networks of CHB TCM syndromes progression analyzed using DAVID online analysis. The results have shown that the difference between TCM syndromes is distinctly based on hierarchical cluster and network structure. GO and pathway analysis implicated that three CHB syndromes more likely have different molecular mechanisms, while the excessive-deficient and deficient syndromes are more dangerous than excessive syndrome in the process of tumorigenesis. This study suggested that miRNAs are important mediators for TCM syndromes classification as well as CHB development progression and therefore could be potential diagnosis and therapeutic molecular markers.

摘要

中医(TCM)治疗被认为是慢性乙型肝炎(CHB)的一种安全有效的方法,需要传统的诊断方法来区分中医证候。在这项研究中,我们通过对 CHB 患者加权 miRNA 表达或 miRNA-靶网络的综合比较分析,研究了实证、实证不足和虚证之间的差异和相似性。我们首先基于随机模块 t 检验计算差异表达的 miRNA,并使用 SVM 方法对三种 CHB TCM 证候进行分类。然后,通过验证数据库和预测程序获得 miRNA 靶基因,随后构建不同 TCM 证候的加权 miRNA-靶网络。此外,使用 DAVID 在线分析程序对 CHB TCM 证候进展的网络优先靶基因进行分析。结果表明,中医证候之间的差异明显基于层次聚类和网络结构。GO 和通路分析表明,三种 CHB 证候可能具有不同的分子机制,而实证不足和虚证在肿瘤发生过程中比实证更危险。这项研究表明,miRNA 是 TCM 证候分类以及 CHB 发展进展的重要介质,因此可能是潜在的诊断和治疗分子标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e317/3652179/7c6e2cd7e6df/ECAM2013-945245.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验